BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25047712)

  • 1. Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase.
    Jain V; Kikuchi H; Oshima Y; Sharma A; Yogavel M
    J Struct Funct Genomics; 2014 Dec; 15(4):181-90. PubMed ID: 25047712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
    Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
    Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
    Chhibber-Goel J; Yogavel M; Sharma A
    Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
    Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
    Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance.
    Tye MA; Payne NC; Johansson C; Singh K; Santos SA; Fagbami L; Pant A; Sylvester K; Luth MR; Marques S; Whitman M; Mota MM; Winzeler EA; Lukens AK; Derbyshire ER; Oppermann U; Wirth DF; Mazitschek R
    Nat Commun; 2022 Aug; 13(1):4976. PubMed ID: 36008486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.
    Saint-Léger A; Sinadinos C; Ribas de Pouplana L
    Bioengineered; 2016 Apr; 7(2):60-4. PubMed ID: 26963157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.
    Keller TL; Zocco D; Sundrud MS; Hendrick M; Edenius M; Yum J; Kim YJ; Lee HK; Cortese JF; Wirth DF; Dignam JD; Rao A; Yeo CY; Mazitschek R; Whitman M
    Nat Chem Biol; 2012 Feb; 8(3):311-7. PubMed ID: 22327401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study.
    Nyamai DW; Tastan Bishop Ö
    Malar J; 2019 Feb; 18(1):34. PubMed ID: 30728021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase.
    Zhou H; Sun L; Yang XL; Schimmel P
    Nature; 2013 Feb; 494(7435):121-4. PubMed ID: 23263184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite Plasmodium falciparum.
    Bhatt TK; Kapil C; Khan S; Jairajpuri MA; Sharma V; Santoni D; Silvestrini F; Pizzi E; Sharma A
    BMC Genomics; 2009 Dec; 10():644. PubMed ID: 20042123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum.
    Hoen R; Novoa EM; López A; Camacho N; Cubells L; Vieira P; Santos M; Marin-Garcia P; Bautista JM; Cortés A; Ribas de Pouplana L; Royo M
    Chembiochem; 2013 Mar; 14(4):499-509. PubMed ID: 23444099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.
    Hewitt SN; Dranow DM; Horst BG; Abendroth JA; Forte B; Hallyburton I; Jansen C; Baragaña B; Choi R; Rivas KL; Hulverson MA; Dumais M; Edwards TE; Lorimer DD; Fairlamb AH; Gray DW; Read KD; Lehane AM; Kirk K; Myler PJ; Wernimont A; Walpole C; Stacy R; Barrett LK; Gilbert IH; Van Voorhis WC
    ACS Infect Dis; 2017 Jan; 3(1):34-44. PubMed ID: 27798837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes in human prolyl-tRNA synthetase upon binding of the substrates proline and ATP and the inhibitor halofuginone.
    Son J; Lee EH; Park M; Kim JH; Kim J; Kim S; Jeon YH; Hwang KY
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2136-45. PubMed ID: 24100331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational heterogeneity in apo and drug-bound structures of Toxoplasma gondii prolyl-tRNA synthetase.
    Mishra S; Malhotra N; Kumari S; Sato M; Kikuchi H; Yogavel M; Sharma A
    Acta Crystallogr F Struct Biol Commun; 2019 Nov; 75(Pt 11):714-724. PubMed ID: 31702585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
    Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
    Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum.
    Manickam Y; Chaturvedi R; Babbar P; Malhotra N; Jain V; Sharma A
    Drug Discov Today; 2018 Jun; 23(6):1233-1240. PubMed ID: 29408369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.
    Xie SC; Metcalfe RD; Dunn E; Morton CJ; Huang SC; Puhalovich T; Du Y; Wittlin S; Nie S; Luth MR; Ma L; Kim MS; Pasaje CFA; Kumpornsin K; Giannangelo C; Houghton FJ; Churchyard A; Famodimu MT; Barry DC; Gillett DL; Dey S; Kosasih CC; Newman W; Niles JC; Lee MCS; Baum J; Ottilie S; Winzeler EA; Creek DJ; Williamson N; Parker MW; Brand S; Langston SP; Dick LR; Griffin MDW; Gould AE; Tilley L
    Science; 2022 Jun; 376(6597):1074-1079. PubMed ID: 35653481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uneven spread of cis- and trans-editing aminoacyl-tRNA synthetase domains within translational compartments of P. falciparum.
    Khan S; Sharma A; Jamwal A; Sharma V; Pole AK; Thakur KK; Sharma A
    Sci Rep; 2011; 1():188. PubMed ID: 22355703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.